These patches of irritated skin can show up anywhere, said Dr. JiaDe Yu, the director of the Atopic Dermatitis Clinic at Massachusetts General Hospital, but they often appear on inner elbows ...

Pediatricians should consider treating children with atopic dermatitis (AD) “proactively,” according to a new clinical report from the American Academy of Pediatrics (AAP). The AAP defines ...

Rocatinlimab exhibited promising results in the phase 3 ROCKET HORIZON trial for the treatment of moderate to severe atopic dermatitis, Kyowa Kirin announced in a press release. Rocatinlimab is an ...

On July 9th, 2024, the U.S. FDA approved Arcutis Biotherapeutics' ZORYVE® (roflumilast) for treating atopic dermatitis (AD), the most common type of eczema affecting millions in the U.S.